Saudi health research institute signs MoU with France’s Sanofi during crown prince’s visit
The National Institute for Health Research signed an MoU with French firm Sanofi to boost research, innovation, and clinical studies in line with Vision 2030.
RIYADH — Dr. Hanan Balkhy has thanked Saudi Arabia for nominating her as Director-General of the World Health Organization for the 2027-2032 term in her first remarks after the announcement. Balkhy highlighted her lifetime in global health, spanning clinical care, infectious disease response, and senior leadership positions. She credited her experience as a pediatrician, infectious disease specialist, and scientist working on the MERS-CoV outbreak for her approach to global health.
Balkhy also expressed her gratitude to the health professionals and colleagues who contributed to her career, as well as WHO staff worldwide. Looking ahead, she emphasized WHO's need to earn trust, deliver impact, and demonstrate value for every member state. Saudi Health Minister Fahad Al-Jalajel announced the nomination, describing Balkhy as a leader with extensive scientific, clinical, and public health experience.
He emphasized her practical leadership in strengthening health systems and achieving better health outcomes for all member states, reflecting Saudi Arabia's commitment to a WHO that is trusted, prepared, and impactful.
Written by urgent.news from Saudi Gazette's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
